Amsterdam

• Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation
  2024-514991-41-01 4 Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
• An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Not authorised
  2022-501463-40-00 5 Locally Advanced or Metastatic Cholangiocarcinoma
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into … Not authorised
  2022-501644-15-00 4 Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
• SAFEST Not authorised
  2022-502059-79-00 6 Ischemic stroke or transient ischemic attack
• A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi … Not authorised
  2022-502099-22-00 5 HIV-1 Infection
• Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Not authorised
  2022-502968-20-01 4 Idiopathic Inflammatory Myopathies
• A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Not authorised
  2023-503631-18-00 5 Nervous system diseases
• ASPIRE-1: dApagliflozin SC0062 and Prevention of renal Injury; a Randomized Evaluation Not authorised
  2023-504404-28-00 4 Chronic Kidney Disease
• Treating discharge and discomfort of eye prosthesis: a comparison between vitamin A ointment, anti-inflammatory eye drops and standard eye d … Not authorised
  2023-504451-27-00 6 Chronic mucopurulent discharge and/or discomfort of the ocular prosthe
• Metal Panel Patch Test Not authorised
  2023-507972-35-00 5 Allergic contact dermatitis Eczema
• Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI … Not authorised
  2024-514693-47-00 11 EGFR mutated locally advanced or metastatic non-small cell lung cancer
• A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with … Not authorised
  2024-515199-10-00 4 Retinitis Pigmentosa
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 5 Ulcerative colitis
• DUAL Pending
  2023-505453-40-00 7 Prostate cancer
• Optimizing Lymph Node Staging in Esophageal Cancer with USPIO-enhanced MRI Pending
  2023-506952-26-01 4 Esophageal cancer
• A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE … Pending
  2023-506982-73-00 4 high risk or poor response after chemoradiation and brachytherapy for
• Phase 2 randomised study of Radspherin® in patients with peritoneal carcinomatosis from colorectal carcinoma after cytoreductive surgery (CR … Pending
  2023-508496-37-00 4 Carcinomatosis of peritoneal cavity
• Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemo … Pending
  2023-508658-24-00 4 type B3 thymoma and thymic carcinoma
• RATE: Reduced anticoagulation targets in extracorporeal life support Pending
  2023-509675-16-01 5 All patients who receive ECMO treatment during the study period in one
• Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial (ActiVitD) Pending
  2023-510312-40-00 6 Secondary hyperparathyroidism
• Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Pending
  2024-510617-15-00 5 Non-metastatic resectable pancreatic cancer
• Neo-adjuvant intraperitoneal chemotherapy (irinotecan) and systemic chemotherapy (mFOLFOX4-bevacizumab) prior to CRS-HIPEC for patients with … Pending
  2024-512318-16-00 4 Patients with colorectal peritoneal metastases with a PCI-score of 1-2
• Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco … Pending
  2024-512850-10-00 5 Resectable colorectal rectal metastases without extrahepatic disease

Showing 1–24 of 1,112 trials